GSD NovaType Select L452R SARS-CoV-2 (1x96)
New Singleplex RT-PCR assay for the detection of the mutation L452R occurring with SARS-CoV-2 variants of concern or variants of interestor variants under monitoring B.1.617.2 (Delta), B.1.427 / B.1.429 (Epsilon), B.1.617.1 (Kappa), B.1.617.3, and B.1.526.1 (Iota).
For Research Use Only.
Not available in the US.
The GSD NovaType Select L452R SARS-CoV-2 is a research use only (RUO) real-time reverse transcription PCR (RT-PCR) Singleplex assay designed for the qualitative detection of the SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) S gene mutation L452R. Sample material should be genomic RNA extracted from human upper respiratory (nasal wash/smear, nasopharyngeal wash/smear, oropharyngeal swab) specimen types that have previously tested positive for SARS-CoV-2 RNA by diagnostic RT-PCR methods e.g. GSD NovaPrime® SARS-CoV-2 (COVID-19).
• Confirmatory test for the detection of the mutation L452R
• Kit Contents: RT-PCR Enzyme Mix, Primer-Probe-Mix, Positive Control, Nuclease Free Water
• Specimen types: nasal wash/smear, nasopharyngeal wash/smear, oropharyngeal swab
• Validated PCR platforms: AriaMxTM and AriaDxTM (Agilent Technologies)
The GSD NovaType Select L452R SARS-CoV-2 is expressly not intended for diagnosis of SARS-CoV-2 infection and not for use in diagnostic procedures. It is only designed to aid investigations related to the prevalence and frequency of virus variants.
|No. of tests||96|
|Specificity||Mutation L452R in SARS-CoV-2 variants|
|PCR cycler platforms||AriaMxTM and AriaDxTM (Agilent Technologies)|
|Kit components||RT-PCR Enzyme Mix, Primer-Probe-Mix, Positive Control, Nuclease Free Water|